RxDoctor Payments Data

Jennifer Bollyky, MD

Internal Medicine · Stanford, CANPI 1497717748

Payments from drug & device makers

$271,725in general payments, 2019–2025

Across 3 payments — averaging $90,575 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$272K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly3$271,725

How this compares

$271,725 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Medicare billing

Part B allowed, 2024
$22,384
Medicare patients
204
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate11$171
Naproxen12$56
Lisinopril11$31

Paid to pharmacies, not to this prescriber.

Other internal medicine in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →